BioSpace News Archive

Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the successful closing of the research collaboration and licensing agreement between Dicerna and Roche following expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.

Salarius Pharmaceuticals, Inc. announced that its chief executive officer, David Arthur, will present at the Biotech Showcase 2020 conference being held January 13-15, 2020 at the Hilton San Francisco Union Square in San Francisco, California.

Immutep Limited, a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, provides an update on the INSIGHT-004 Phase I clinical trial to evaluate the combination of eftilagimod alpha with avelumab, a human anti-PD-L1 antibody, in patients with advanced solid malignancies.

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the Company’s Board of Directors has authorized a 1-for-700 reverse stock split of the Company’s common stock.

Ultragenyx Pharmaceutical Inc. announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 12:00 pm PT in San Francisco..

PDL BioPharma, Inc. announced upcoming changes to the Company’s Board of Directors.

Embera appoints Bruce McCarthy, M.D. as Chief Medical Officer Gary Connor, RN promoted to Chief Operating Officer

Awards of $10 Million in 2019 Granted to More Than 400 Organizations in 32 States

The AOAC’s Performance TestedSM Method Certification provides independent validation of the ability of the Soleris for EBAC test to accurately detect EBAC in a wide variety of sample types.

SK Holding’s CEO Donghyun Jang met AstraZeneca’s Chairman Leif Johansson on December 19th. “We will continue to strengthen the cooperation between the two companies” said Mr. Jang.